Abstract
Activation of Gq-type G protein-coupled receptors (GPCRs) gives rise to large cytosolic Ca2+ elevations in astrocytes. Previous in vitro and in vivo studies have indicated that astrocytic Ca2+ elevations are closely associated with diameter changes in the nearby blood vessels, which astrocytes enwrap with their endfeet. However, the causal relationship between astrocytic Ca2+ elevations and blood vessel diameter changes has been questioned, as mice with diminished astrocytic Ca2+ signaling show normal sensory hyperemia. We addressed this controversy by imaging cortical vasculature while optogenetically elevating astrocyte Ca2+ in a novel transgenic mouse line, expressing Opto-Gq-type GPCR Optoα1AR (Astro-Optoα1AR) in astrocytes. Blue light illumination on the surface of the somatosensory cortex induced Ca2+ elevations in cortical astrocytes and their endfeet in mice under anesthesia. Blood vessel diameter did not change significantly with Optoα1AR-induced Ca2+ elevations in astrocytes, while it was increased by forelimb stimulation. Next, we labeled blood plasma with red fluorescence using AAV8-P3-Alb-mScarlet in Astro-Optoα1AR mice. We were able to identify arterioles that display diameter changes in superficial areas of the somatosensory cortex through the thinned skull. Photo-stimulation of astrocytes in the cortical area did not result in noticeable changes in the arteriole diameters compared with their background strain C57BL/6. Together, compelling evidence for astrocytic Gq pathway-induced vasodiameter changes was not observed. Our results support the notion that short-term (<10 s) hyperemia is not mediated by GPCR-induced astrocytic Ca2+ signaling.
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | 13590 |
| Tidsskrift | International Journal of Molecular Sciences |
| Vol/bind | 24 |
| Udgave nummer | 17 |
| Antal sider | 12 |
| ISSN | 1661-6596 |
| DOI | |
| Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:This research was funded by KAKENHI grants (23115522, 26117520 (Ha.H.), 15K14326 (Y.I.), 22K06454 (A.K.)), the Novo Nordisk Foundation (NNFOC0058058) (Ha.H.), Danmarks Frie Forskningsfond (0134-00107B) (Ha.H), the Lundbeck Foundation, National Institute of Health (U19NS128613) (Mai.N., Ha.H.), JSPS Core-to-Core Program, and the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development, AMED, under Grant Number JP21dm0207111 (Hi.H.), The Naito Foundation (Mas.N).
Publisher Copyright:
© 2023 by the authors.
Finansiering
This research was funded by KAKENHI grants (23115522, 26117520 (Ha.H.), 15K14326 (Y.I.), 22K06454 (A.K.)), the Novo Nordisk Foundation (NNFOC0058058) (Ha.H.), Danmarks Frie Forskningsfond (0134-00107B) (Ha.H), the Lundbeck Foundation, National Institute of Health (U19NS128613) (Mai.N., Ha.H.), JSPS Core-to-Core Program, and the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development, AMED, under Grant Number JP21dm0207111 (Hi.H.), The Naito Foundation (Mas.N).
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS